Hsiaolin Chang currently serves as the Chief Financial Officer at Cyclopure, a position held since 2025. Previously, Hsiaolin worked as Vice President of Finance at Genezen from 2023 to 2025, and was a Finance Controller at Orum Therapeutics in 2022. With a diverse background in financial roles, they have also held positions at Arranta Bio, Sarepta Therapeutics, and KPMG Audit. Hsiaolin earned both a Master of Science in Accounting and a Bachelor of Business Administration in Accounting from the Isenberg School of Management at UMass Amherst.
This person is not in any teams
This person is not in any offices